NCT04410315View on ClinicalTrials.gov

Hyperlactatemia During and After Tumorcraniotomy

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

February 18, 2022

Study Completion Date

February 18, 2022

Conditions
HyperlactatemiaBrain TumorSurgeryAnesthesia
Interventions
OTHER

Serum-lactate < 2,2 mmol/L

Bloodgas analysis every hour from start surgery until recovery ward discharge

OTHER

Serum-lactate >/= 2,2 mmol/L

Bloodgas analysis every hour from start surgery until recovery ward discharge

Trial Locations (1)

Unknown

Department of Neuroanesthesiology, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT04410315 - Hyperlactatemia During and After Tumorcraniotomy | Biotech Hunter | Biotech Hunter